Emerald Health Therapeutics Inc. (EHT) launched a multi-pronged program to market and sell a proprietary, non-cannabis line of endocannabinoid-supporting nutritional products in Canadian grocery, natural health product, and pharmacy stores. EHT has entered into a 51:49 joint venture, to be called Emerald Health Naturals (EHN), with Emerald Health Bioceuticals, Inc. (EHB). EHN has secured exclusive Canadian marketing and sales rights to EHB's unique nutritional supplements, which use non-cannabis, non-psychoactive plant-based ingredients to provide potentially beneficial support to the body's endocannabinoid system.

In this initiative, EHN has agreed to acquire the assets of GAB Innovations (GAB) and has granted non-exclusive sub-distribution rights to VANC Pharmaceuticals (VANC). Both GAB and VANC have established networks and a history of sales success in the natural health product and pharmacy channels. Gaetano Morello, ND, the founder of GAB, has been appointed CEO of EHN.

EHT is leveraging multiple relationships to launch this initiative: Formed a joint venture with Emerald Health Bioceuticals. EHT will receive 51% of the shares of EHN in exchange for an investment of $5,000,000. EHB will receive 49% of the shares of EHN in exchange for granting the joint venture exclusive Canadian distribution rights with respect to EHB's product line.

EHB developed and launched its over-the-counter product line of cannabis-free nutritional supplements in the U.S. The products feature PhytoCann-Complex™, EHB's proprietary formulation designed to support the body's endocannabinoid system and its central role in the orchestration, maintenance, and balance of health and wellbeing. The products include Endo Sleep™, Endo Inflame™, Endo Brain™, Endo Bliss™, Endo Calm™. EHB is a 70%-owned subsidiary of Emerald Health Sciences Inc. (Sciences), which also owns approximately 37% of the issued and outstanding shares of EHT.

There will be no change in the share ownership of EHT by Sciences as a result of the joint venture. The joint venture with EHB was approved by the independent directors of EHT. Appointed Gaetano Morello, ND, as CEO of EHN.

He serves on the Quality Assurance Committee for the College of Naturopathic Physicians of British Columbia and other health and medical panels.